Benfotiamine PCD Pharma Franchise Company

Cafoli Lifecare offers a Benfotiamine range of 10 formulations across tablets, capsules and softgels, manufactured in WHO-GMP certified facilities. Distributors targeting the large diabetes and neuropathy market can secure district-wise monopoly franchise rights with full promotional support.

What is Benfotiamine?

Benfotiamine is a fat-soluble, highly bioavailable derivative of thiamine (vitamin B1). Because it achieves higher tissue thiamine levels than water-soluble B1, it is used to support nerve health and is widely combined with other neurotropic vitamins in the management of diabetic peripheral neuropathy and other neuropathic conditions. Reference: PubChem - Benfotiamine.

Available Forms

The Cafoli Benfotiamine portfolio spans oral Tablets, Capsules and Softgels, often formulated with methylcobalamin, alpha-lipoic acid, pyridoxine and folic acid. Contact us for current pack presentations and combinations.

Therapeutic Applications

Benfotiamine is prescribed for diabetic peripheral neuropathy, other peripheral neuropathies, nerve-related pain and thiamine deficiency states. Prescribers include diabetologists, endocrinologists, neurologists, orthopaedic surgeons and general physicians.

Why Benfotiamine is a High-Potential Molecule for Distributors

India's very large and growing diabetic population makes neuropathy supplements a high-volume, chronic-use category, and benfotiamine is a core ingredient in almost every neuro-vitamin combination that diabetologists prescribe daily. Long-term dosing and frequent co-prescription with anti-diabetic therapy translate into strong, predictable repeat sales for the distributor.

Why Choose Cafoli Lifecare

Cafoli Lifecare offers monopoly franchise rights, WHO-GMP certified manufacturing, DCGI-approved formulations, a network of 1000+ franchise partners across India, and free promotional inputs.

References

1. PubChem: Benfotiamine
2. PubMed: benfotiamine in diabetic neuropathy
3. MedlinePlus: Thiamine